Cover Your Bases Campaign Kicks Off Oral Health Month With ARESTIN (minocycline HCI) Patient Ambassador Alex Rodriguez
LAVAL, QC, May 31, 2023 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its oral care business, OraPharma, today announced their partnership with the World Series Champion, Alex Rodriguez, to launch a national awareness campaign about the prevalence and impact of gingivitis. The Cover Your Bases The campaign includes educational content about the disease and encourages patients to talk to their dentist about comprehensive treatment options. The campaign launch is timed to coincide with Oral Health Month which is recognized throughout June and features Alex as a patient ambassador.
Experience the full interactive Multichannel Newsletter here:
According to the American Dental Association, gum disease affects nearly 65 million Americans nationwide. More specifically, nearly half of Americans age 30 and older and 70% of those age 75 and older have some form of gingivitis. The most common symptoms of gum disease include bleeding during or after brushing and red or swollen gums. Some studies suggest that gum disease may be associated with an increased risk of other chronic conditions throughout the body, such as diabetes and heart disease.
“Throughout my life and career, I’ve always put a lot of energy into prioritizing my health, so I was shocked when my dentist told me I had early-stage gum disease,” Rodriguez said. “My dentist also informed me that gum disease is more common in men and in the Latino community, so I felt it was very important for me to share my story. I was lucky to catch it early and if it can happen to me , it can happen to anyone.”
Although there is no cure for gum disease, it is important to consider comprehensive treatment plans that may include ARESTIN – an antibiotic used in combination with scaling and root planing (SRP) to treat adult periodontitis, also known as as gum disease. ARESTIN is applied to the site of infection, helping to fight the bacteria that cause gingivitis. ARESTIN can be used as part of a general health program that includes good brushing and flossing habits and SRP.
ARESTIN should not be taken if you are allergic to minocycline or tetracyclines. Ask your dentist or pharmacist for a list of these medicines if you are not sure. The use of tetracycline class drugs, including ARESTIN, during tooth development may cause permanent tooth discoloration and therefore should not be used in children or in pregnant or nursing women. See below for additional important safety information about ARESTIN.
“This campaign is the first of its kind for OraPharma and we couldn’t be more excited to have Alex share his expertise to not only help educate patients about this often misunderstood and underdiagnosed disease, but and to encourage them to talk to their dentist,” he said Tom Stern, Vice President and General Manager at OraPharma. “We hope this campaign will help raise awareness of gum disease and empower others to take charge of their dental health by seeking appropriate treatment options that may help manage this serious disease.”
To learn more about a treatment option and hear Alex’s story, visit www.Arestin.com.
About ARESTIN®
INDICATION
ARESTIN® (minocycline HCl) Microspheres, 1 mg is used in conjunction with scaling and root planing (SRP) procedures to treat patients with adult periodontitis (gingivitis). ARESTIN® can be used as part of a general oral health program that includes good brushing and flossing habits and SRP.
IMPORTANT SAFETY INFORMATION
- Do not take ARESTIN if you are allergic to minocycline or tetracyclines. Ask your dentist or pharmacist for a list of these medicines if you are not sure. Facial swelling, skin itching, fever, and enlarged lymph nodes have been reported with the use of ARESTIN. Some of these reactions were severe. Tell your dentist right away if you have signs of an allergic reaction, such as skin reactions or difficulty breathing, or if you have an exaggerated sunburn reaction.
- THE USE OF TETRACYCLINE CLASS DRUGS, INCLUDING ARESTIN, DURING TEETH DEVELOPMENT CAN CAUSE PERMANENT TEETH DISCOLORATION AND THEREFORE SHOULD NOT BE USED IN CHILDREN OR PREGNANT WOMEN .
- ARESTIN has not been studied in patients with a weakened immune system (such as patients with HIV infections or diabetes, or patients receiving chemotherapy or radiation). Tetracyclines, including oral minocycline, have been associated with the development of an autoimmune syndrome with symptoms such as joint pain, muscle pain, rash, swelling, fever, enlarged lymph nodes, and general body weakness. Tell your doctor about any health problems you have, including whether you have had oral candidiasis (“thrush”) in the past, and about all medications you are taking.
- In clinical studies, the most commonly reported non-dental side effects were headache, infection, flu-like symptoms, and pain.
We encourage you to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
click here for complete prescribing information.
About OraPharma
OraPharma is a specialty pharmaceutical company committed to working with dental professionals to improve oral health. Founded more than 25 years ago, OraPharma includes a curated portfolio of treatments for periodontal disease, malocclusion and multiple regenerative solutions for oral surgery. More information can be found at https://www.orapharma.com/.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people’s lives with our healthcare products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health through our control for Bausch + Lomb. With our leading durable brands, we deliver on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us Twitter and LinkedIn.
ARE.0118.USA.23
SOURCE OraPharma
